Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the Prostate
Billing code will take effect July 1st, 2017 LYON, France , May 22, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the Centers for Medicare and Medicaid Services (CMS) have established a new billing code for HIFU ablation of
View HTML
Toggle Summary EDAP TMS SA Reports First Quarter 2017 Results
Total revenue of EUR 8.7 million ( USD 9.3 million ) for Q1 2017  +16.5% growth in HIFU treatment driven recurring revenues Strong cash position of EUR 20.3 million ( USD 21.7 million ) as of March 31, 2017 CMS Medicare C-code submission for HIFU reimbursement in the U.S.
View HTML
Toggle Summary EDAP Announces Ablatherm Fusion World Premiere during American Urology Association Annual Meeting in Boston, MA, May 12-16, 2017
EDAP Announces Ablatherm Fusion World Premiere during American Urology Association Annual Meeting in Boston, MA , May 12-16, 2017 EDAP to Showcase Ablatherm Fusion and Sonolith i-move at AUA Booth #130 LYON, France , May 11, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic
View HTML
Toggle Summary EDAP TMS SA to Report First Quarter 2017 Financial Results on May 17, 2017
LYON, France , May 2, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2017 , after the close of the financial markets on May 17, 2017 .
View HTML
Toggle Summary EDAP Achieves 63% Growth in HIFU Revenue in 2016
2016 Highlights Total revenue for 2016 reached double-digit growth, increasing to EUR 35.6 million ( USD 39.3 million ) Gross margin for 2016 expanded to 46.1% compared to 42.8% during the prior year period Strong cash position of EUR 22.0 million ( USD 23.2 million ) as of December 31, 2016 LYON,
View HTML
Toggle Summary EDAP's Ablatherm® Robotic HIFU: Clinical Results Support High-Intensity Focused Ultrasound (HIFU) for Prostate Tissue Ablation after Unsuccessful Radiotherapy
Multicenter Retrospective Analysis of 418 Patients  LYON, France , March 22, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU for prostate tissue ablation in patients who
View HTML
Toggle Summary EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017
EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017 LYON, France , March 14, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the fourth quarter and year ended December 31,
View HTML
Toggle Summary EDAP's Long Term Academic HIFU Partner INSERM LabTAU Designated Center of Excellence by the Focused Ultrasound Foundation
EDAP's Long Term Academic HIFU Partner INSERM LabTAU Designated Center of Excellence by the Focused Ultrasound Foundation LYON, France, March 8, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that the prestigious Focused Ultrasound Foundation,
View HTML
Toggle Summary EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the U.S.
EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the U.S. LYON, France , March 6, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the appointment of Noah J. Bartsch as Vice President of Global Medical, Regulatory, and
View HTML
Toggle Summary EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota
EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota LYON, France , February 27, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at the University of Minnesota , Minneapolis ,
View HTML